Canopy Growth (CGC) Goodwill & Intangibles (2017 - 2026)
Canopy Growth (CGC) reported Goodwill & Intangibles of $213.7 million for Q1 2026, up 130.15% on a YoY basis from $92.9 million in Q1 2025, and up 140.95% sequentially from $88.7 million in Q4 2025.
Canopy Growth (CGC) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Goodwill & Intangibles data on file, last reported at $213.7 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 130.15% year-over-year to $213.7 million; the trailing twelve-month figure through Mar 2026 stood at $213.7 million (up 130.15% YoY), and the FY2026 full-year result was $213.7 million, up 130.15% from the prior year.
- Goodwill & Intangibles grew to $213.7 million in Q1 2026, from $88.7 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $1.6 billion in Q1 2022 to a low of $72.4 million in Q2 2025.
- A 5-year average of $251.9 million and a median of $173.5 million in 2023 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles sank 90.27% in 2023 and surged 130.15% in 2026, its largest moves.
- Tracing CGC's Goodwill & Intangibles over 5 years: stood at $269.8 million in 2022, then decreased by 22.17% to $210.0 million in 2023, then sank by 54.37% to $95.8 million in 2024, then decreased by 7.45% to $88.7 million in 2025, then soared by 140.95% to $213.7 million in 2026.
- Business Quant data shows CGC's Goodwill & Intangibles at $213.7 million in Q1 2026, $88.7 million in Q4 2025, and $94.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Canopy Growth | 276.52 Mn | 10.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213.71 Mn |
| Dec 31, 2025 | 88.70 Mn |
| Sep 30, 2025 | 94.02 Mn |
| Jun 30, 2025 | 72.40 Mn |
| Mar 31, 2025 | 92.86 Mn |
| Dec 31, 2024 | 95.84 Mn |
| Sep 30, 2024 | 180.87 Mn |
| Jun 30, 2024 | 83.09 Mn |
| Mar 31, 2024 | 109.31 Mn |
| Dec 31, 2023 | 210.02 Mn |
| Sep 30, 2023 | 173.52 Mn |
| Jun 30, 2023 | 199.01 Mn |
| Mar 31, 2023 | 160.10 Mn |
| Dec 31, 2022 | 269.85 Mn |
| Sep 30, 2022 | 270.83 Mn |
| Jun 30, 2022 | 322.66 Mn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 1.76 Bn |
| Sep 30, 2021 | 1.78 Bn |
| Jun 30, 2021 | 1.91 Bn |